Ghost Tree Capital as of Dec. 31, 2016
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 66 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 8.6 | $36M | 600k | 59.19 | |
| Abbott Laboratories (ABT) | 5.5 | $23M | 600k | 38.41 | |
| Shire | 4.1 | $17M | 100k | 170.38 | |
| Boston Scientific Corporation (BSX) | 3.9 | $16M | 750k | 21.63 | |
| Bristol Myers Squibb (BMY) | 3.5 | $15M | 250k | 58.44 | |
| Alexion Pharmaceuticals | 3.4 | $14M | 115k | 122.35 | |
| Zimmer Holdings (ZBH) | 3.2 | $13M | 130k | 103.20 | |
| Merck & Co (MRK) | 3.2 | $13M | 225k | 58.87 | |
| ACADIA Pharmaceuticals (ACAD) | 3.1 | $13M | 450k | 28.84 | |
| Celgene Corporation | 3.1 | $13M | 110k | 115.75 | |
| Dbv Technologies S A (DBVT) | 2.8 | $11M | 325k | 35.13 | |
| Sage Therapeutics (SAGE) | 2.5 | $10M | 200k | 51.06 | |
| NuVasive | 2.4 | $10M | 150k | 67.36 | |
| Clovis Oncology | 2.4 | $9.8M | 220k | 44.42 | |
| Avexis | 2.0 | $8.4M | 175k | 47.73 | |
| Spectranetics Corporation | 2.0 | $8.2M | 335k | 24.50 | |
| Seattle Genetics | 1.9 | $7.9M | 150k | 52.77 | |
| Intercept Pharmaceuticals In | 1.8 | $7.6M | 70k | 108.66 | |
| Neuroderm Ltd F | 1.8 | $7.3M | 330k | 22.20 | |
| BioCryst Pharmaceuticals (BCRX) | 1.8 | $7.3M | 1.2M | 6.33 | |
| Glaukos (GKOS) | 1.6 | $6.9M | 200k | 34.30 | |
| Lion Biotechnologies | 1.6 | $6.8M | 975k | 6.95 | |
| Mallinckrodt Pub | 1.6 | $6.7M | 135k | 49.82 | |
| Aerie Pharmaceuticals | 1.6 | $6.6M | 175k | 37.85 | |
| Nevro (NVRO) | 1.6 | $6.5M | 90k | 72.66 | |
| Immunomedics | 1.5 | $6.2M | 1.7M | 3.67 | |
| Puma Biotechnology (PBYI) | 1.5 | $6.1M | 200k | 30.70 | |
| Flamel Technologies | 1.4 | $6.0M | 575k | 10.39 | |
| Agios Pharmaceuticals (AGIO) | 1.4 | $5.8M | 140k | 41.73 | |
| Perrigo Company (PRGO) | 1.4 | $5.8M | 70k | 83.23 | |
| Epizyme | 1.4 | $5.7M | 475k | 12.10 | |
| Nanostring Technologies (NSTGQ) | 1.3 | $5.6M | 250k | 22.30 | |
| Sarepta Therapeutics (SRPT) | 1.3 | $5.5M | 200k | 27.43 | |
| CurrencyShares Swiss Franc Trust | 1.1 | $4.3M | 46k | 93.73 | |
| Biogen Idec (BIIB) | 1.0 | $4.3M | 15k | 283.60 | |
| Endo International (ENDPQ) | 1.0 | $4.1M | 250k | 16.47 | |
| Foamix Pharmaceuticals | 1.0 | $4.1M | 365k | 11.10 | |
| Wright Medical Group Nv | 1.0 | $4.0M | 175k | 22.98 | |
| Spark Therapeutics | 1.0 | $4.0M | 80k | 49.90 | |
| Qiagen | 0.9 | $3.8M | 135k | 28.02 | |
| Entellus Medical Cm | 0.9 | $3.8M | 200k | 18.97 | |
| Aquinox Pharmaceuticals | 0.9 | $3.7M | 225k | 16.51 | |
| Irhythm Technologies (IRTC) | 0.8 | $3.5M | 115k | 30.00 | |
| Aclaris Therapeutics (ACRS) | 0.8 | $3.3M | 120k | 27.14 | |
| IRIDEX Corporation (IRIX) | 0.7 | $2.8M | 200k | 14.06 | |
| Zogenix | 0.7 | $2.7M | 225k | 12.15 | |
| Medicines Company | 0.6 | $2.5M | 75k | 33.95 | |
| Xenon Pharmaceuticals (XENE) | 0.6 | $2.5M | 325k | 7.70 | |
| Tesaro | 0.6 | $2.3M | 17k | 134.47 | |
| Horizon Pharma | 0.5 | $2.1M | 129k | 16.18 | |
| Bluebird Bio (BLUE) | 0.5 | $1.9M | 30k | 61.70 | |
| Inotek Pharmaceuticals | 0.4 | $1.8M | 300k | 6.10 | |
| Rigel Pharmaceuticals (RIGL) | 0.4 | $1.7M | 700k | 2.38 | |
| Veracyte (VCYT) | 0.4 | $1.5M | 200k | 7.74 | |
| Incyte Corporation (INCY) | 0.3 | $1.3M | 13k | 100.31 | |
| Ra Pharmaceuticals | 0.3 | $1.1M | 75k | 15.19 | |
| Alcobra | 0.2 | $1.1M | 500k | 2.10 | |
| Acceleron Pharma | 0.2 | $1.0M | 40k | 25.52 | |
| Vtv Therapeutics Inc- Cl A | 0.2 | $966k | 200k | 4.83 | |
| Ariad Pharmaceuticals | 0.2 | $933k | 75k | 12.44 | |
| Mirati Therapeutics | 0.2 | $818k | 172k | 4.75 | |
| Vanda Pharmaceuticals (VNDA) | 0.2 | $734k | 46k | 15.96 | |
| Ophthotech | 0.1 | $416k | 86k | 4.83 | |
| Acorda Therapeutics | 0.1 | $376k | 20k | 18.80 | |
| Synergy Pharmaceuticals | 0.1 | $335k | 55k | 6.09 | |
| Akari Therapeutics | 0.1 | $328k | 47k | 7.04 |
